Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Preventing Transmission of Bloodborne Pathogens In Health Care Settings Effective Date: Status: Originated by: Adopted by: Purpose: To ensure that employees in health care settings are provided with essential tools to prevent transmission of bloodborne pathogens. ANA’s Position: Although the risks of transmission of bloodborne pathogens in health care settings are real and growing – both to patients and health care professionals – such transmission is preventable. Basic principles of public health and occupational safety require that health care settings provide workers with swift and meaningful access to essential tools to prevent transmission of bloodborne pathogens. It is the position of the American Nurses Association that employers in the health care field should implement policies designed to promote safety and reduce the risks of transmission of bloodborne pathogens and laws and regulations promoting safety in health care settings are vigorously enforced on an ongoing basis. History/Previous Position Statements: Supportive Material: In the early 1990s, when the risk of transmission of bloodborne pathogens in health care settings first attracted significant public attention, information was limited regarding the magnitude of the risk and the effectiveness of particular prevention strategies. More than a decade later, however, a substantial body of data provides clear guidance regarding formulation of policy to prevent such transmission. Despite the wealth of information now available regarding strategies to promote occupational safety in health care settings, the National Institute for Occupational Safety and Health reports that rates of occupational injury to health care workers have actually risen in the last decade, underscoring the need for greater attention to safety issues in health care settings and more rigorous enforcement of applicable regulations. Sharps injuries account for the majority of cases of transmission of bloodborne pathogens in health care settings. Pathogens of particular note include HIV, hepatitis C (HCV), and hepatitis B (HBV). • Risk of Transmission. Per-episode risk of transmission to health care workers from a needlestick injury involving an HIV-infected patient is). 3% for HIV, 1.8% for HCV, and 630% for HBV. Factors influencing likelihood of transmission include the pathogen involved, nature of exposure, amount of blood involved in the episode, and viral load of the infected individual. Risk of HIV transmission is about one-third lower for exposures involving the eye, nose or mouth than for percutaneous exposure. Exposure of intact skin is believed to pose no risk at all, although a risk of exposure could exist in cases of prolonged exposure or when the skin has been damaged. • Universal Precautions. The most effective means of avoiding exposure to bloodborne pathogens in health care settings is adherence to universal precautions, which regards all individuals as potentially infectious. Universal precautions apply to blood and a wide range of body fluids specified in recommendations promulgated by the Centers for Disease Control (CDC). Universal precautions require use of protective barriers such as gloves, gowns, aprons, masks and protective eyewear. Following implementation of universal precautions in the 1980s, the frequency of potential exposures to bloodborne pathogens significantly declined. • Safe Devices. Prevention measures to reduce the risk of bloodborne exposures in health care settings have long included safe injection practices (e.g., prohibition on re-use of injection equipment) and mechanisms for safe sharps disposal. In recent years, a number of important technological developments have significantly improved the ability of health care settings to protect workers and patients from the risk of bloodborne exposures. Such technologies include safer injection equipment (e.g., needle guards, needleless injection mechanisms, retractable needles), improved delivery systems for intravenous medications, safer intravenous insertion equipment, improved mechanisms for blood collection, blunt suture needles, safety scalpels and safer lancets. • Pre-Exposure Vaccination. A vaccine does not exist for either HIV or HCV. OSHA requires that all healthcare workers at risk of occupational exposure to blood or body fluids are offered the Hepatitis B vaccine within 10 working days of initial assignment after the employee has received training. The vaccine is to be offered at no cost to the employee. • Post-Exposure Prophylaxis. Studies suggest that administration of antiretroviral therapy following a percutaneous blood exposure reduces the risk of transmission of HIV. The U.S. Public Health Service recommends a four-week course of two drugs or more drug PEP regimen from the five classes of antiretroviral agents available with the initiation of the post-exposure regimen to begin as soon after exposure as possible (preferably within hours). Post-exposure regimens for HIV can result in notable, although typically manageable, side effects, underscoring the importance of medical monitoring during the four-week course of treatment. Employees who have not been vaccinated for HBV and who experience a potential blood exposure should be swiftly vaccinated for HBV. Recommendations: Employers in the health care field: Federal law obligates employers in the health care field to implement policies deigned to promote safety. Mandates to generate a list of job classifications where employees are at risk of occupational exposure by skin, mucous membranes, eye or parenteral contact with blood or other potentially infectious materials that may result from the performance of the employee’s work duties. In addition, employers must generate a list of all tasks and procedures or groups of closely related tasks and procedures in which occupational exposure occurs. Employers must generate clear safety policies and procedures, provide necessary training and re-education to employees, monitor the workplace to ensure compliance with policies, and redesign the workplace to reduce the risk of disease transmission. It is recommended that employers in the health care field: • Promulgate clear policies and procedures, in compliance with federal and state legal mandates and regulations, to promote worker safety and reduce the risk of transmission of blood borne pathogens. • Provide employees with equipment needed for adherence to universal precautions, including gloves, gowns, goggles, and other technologies that comply with state-of-theart quality standards. • Develop, implement and evaluate comprehensive educational and training programs and training to for all employees regarding universal precautions, use of safer medical devices, and pre- and post-exposure prophylaxis options. All new employees should receive comprehensive infection control training before being placed in situations where a blood borne exposure is possible. Infection control education and training should be periodically reinforced (at least once annually, but no greater than 12 months apart and more frequently in the case of important new developments) for existing workers. • Monitor incidents and injuries related to needlestick injuries related to needlestick injuries on an ongoing basis. Implement strategies to decrease exposures and injuries. Assess the effectiveness of new technology post implementation and to identify opportunities for improvement. • Continually monitor technological developments that promote the safety of workers and/or patients. Employers should provide meaningful access to safer, state-of-the-art medical devices and should reconfigure policies, procedures and physical spaces so as to promote routine use of safer devices. Non-managerial employees responsible for direct patient care who have risk of exposure to injuries from contaminated sharps should be included in the identification, evaluation and selection of effective engineering and work practice controls. Newly developed technologies that promote health care and workplace safety should be rapidly integrated into workplace policies and procedures (including applicable education and training protocols). • Non-managerial employees responsible for direct patient care who have risk of exposure to injuries from contaminated sharps should be included in the identification, evaluation and selection of effective engineering and work practice controls. Newly developed technologies that promote health care and workplace safety should be rapidly integrated into workplace policies and procedures (including applicable education and training protocols). • Provide employees with meaningful opportunities to be vaccinated for HBV. Vaccination should be provided free of charge, and employees should be periodically informed of the availability and importance of HBV vaccination and have access to appropriate counseling. • Develop clear, enforceable protocols for post-exposure HIV, HBV and HCV exposure with post exposure prophylaxis, as indicated. Such policies and procedures should be clearly communicated to all employees who might reasonably be exposed to blood or body fluids. Such policies and procedures must, at a minimum, include designation of an official infection control supervisor within the institution, maintenance of sufficient supplies of post-exposure regimens, and employee access to evaluation, treatment and counseling 24 hours a day for blood exposures to facilitate rapid initiation of prophylactic treatments. Employee Obligations: Nurses and healthcare employees within health care organizations should attend comprehensive infection control training and education provided by employers before being placed in situations where a blood borne exposure is possible. Additionally, all nurses and healthcare employees should remain current in infection control procedures by attending education and training sessions at least annually and no greater than 12 months apart and more frequently in the case of important new developments. Nurses and healthcare providers need to be vigilant in identifying situations that are high risk and undertake appropriate precautions, to protect themselves and others from needlestick injury. If an injury does occur, the nurse and/or healthcare employee should report the injury and comply with post exposure protocols. It is recommended that employees in the health care field: • Attend education and training programs provided by employer • Maintain and enhance knowledge base and competency related to infection control techniques • Comply with infection control protocols to reduce risk of exposure to bloodborne pathogens • Notify employer of high-risk situations so that systems can be monitored, evaluated and enhanced to improve safety in the work environment. • Utilize supplies and equipment appropriately to reduce risks posed by bloodborne pathogens. Communicate equipment and supply needs to employer when needs are identified. • Maintain vigilance in the identification of high-risk situations to alert employers and co-workers in an effort to reduce risk and enhance safety. • In the event of an exposure and/or injury, report the exposure to the appropriate personnel and comply with exposure protocols. Law and Regulations Enforcement: It is recommended that laws and regulations promoting safety in health care settings should be vigorously enforced on an ongoing basis. Employers in the health care field that violate work safety measures should be subject to severe fines and other enforcement measures. Enforcement authorities should receive sufficient financing to monitor compliance with applicable workplace safety rules. References: D Cardo et al., A Case-Control Study of HIV Seroconversion in Health Care Workers After Percutaneous Exposure, New Eng J Med 1997;337:1485-90. Centers for Disease Control and Prevention, Guidelines for Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public-Safety Workers, MMWR 1989;38(S-6):1-36. Centers for Disease Control and Prevention, Recommendations for Follow-Up of Health Care Workers After Occupational Exposure to Hepatitis C Virus, MMWR 1997;46:603-606. Centers for Disease Control and Prevention, Recommendations for Prevention of HIV Transmission in Health-Care Settings, MMWR 1987;36(supp. No. 2S). Centers for Disease Control and Prevention, Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis, MMWR 2001;50(No. RR-11). Centers for Disease Control and Prevention, Update: Universal Precautions for Prevention of Human Immunodeficiency Virus, Hepatitis B Virus, and Other Bloodborne Pathogens in HealthCare Settings, MMWR 1988;37:377-88. International Health Care Worker Safety Center, University of Virginia, Information on Safety Devices in Health-Care Settings, available at www.med.virginia.edu/medcntr/centers/epinet/products.html. S Mast et al., Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury, J Infect Dis 1993;168:1589-92. National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Exposure to Blood: What Health-Care Workers Need to Know, available at www.cdc.gov/niosh . L. Seeff et al., Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study, Ann Intern Med 1978;88:285-93. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendtions for Postexposure Prophylaxis, MMWR September 30, 2005:50 (No. RR-9) U.S. Department of Labor, Occupational Safety and Health Administration, Regulation (Standards-29 CFR) Bloodborne pathogens – 1910.1030; 1-33.